News
6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts say lenacapavir is easier to administer, and each dose lasts longer compared to other medications.
WDAM on MSN4h
FDA approves twice-yearly injectable for HIV prevention; local agency weighs in on impact in the Pine BeltThe medical community has reached another milestone that could put an end to the decades-long HIV epidemic. The Food & Drug ...
Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.
Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback